Benefits (Research Focus) Combined GHRH + GHS-R activation studied for paired pathway stimulation of the somatotropic axis Pulsatile GH release investigated for physiologic-pattern growth hormone release in research models IGF-1 axis signaling explored for downstream hepatic IGF-1 production and somatotropic endpoints Visceral adipose research examined for VAT-specific endpoints via the tesamorelin component in lipodystrophy models Hormone selectivity researched for ipamorelins reported minimal off-target effects on cortisol, prolactin, and ACTH What Researchers Look At Plasma GH and IGF-1 dynamics following paired peptide administration Pulsatile vs sustained GH release across paired GHRH and GHS-R stimulation Visceral adipose tissue (VAT) measurements via CT or MRI in lipodystrophy research models Cortisol, prolactin, and ACTH response panels (selectivity markers) Comparative pharmacology versus single-component administration of either peptide Quick Specs Form: Lyophilized white powder Tesamorelin: 10 mg per vial Ipamorelin: 3 mg per vial Total Peptide Content: 13 mg per vial Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC (per component) Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound 1: Tesamorelin Synonyms: TH9507
Notificar-me quando o produto estiver disponvel Aviso sobre as informaes do nosso produto Tambm disponvel: Em cpsulas Servios: 150 Tamanho da dose: 2 doseadores de 0,5ml (1000mg) Toma diria recomendada: 6 doseadores de 0,5 ml (3000 mg) Ingredientes L-carnitina L-tartarato (2:1)
Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MK, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Sjogren K, Liu JL, Blad K, et al
Many users pair their early doses with short, pleasant UV sessions to accelerate the development of their tan, then shift to easy maintenance mode for lasting results
